← Back to All Filings

Zai Lab Officer Files to Sell $55K in Stock for Tax Obligations

Low SignificanceMarch 13, 2026 at 3:50:35 PM EDT

Zai Lab Ltd

$ZLAB144CIK: 0001704292

Subscribe to track ZLAB

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Zai Lab Officer Files to Sell $55K in Stock for Tax Obligations

Company: Zai Lab Ltd Form: 144 | Filed: 2026/03/13 Significance: Low

Insider: Amado Rafael Title: Officer | Relationship: Officer

Transaction: • Type: Sell (Proposed) • Shares: 2,957 • Price: ~$18.63 • Value: $55,083.59 • Nature: Tax Obligation Settlement

Key Insight: Routine transaction. The filing explicitly states shares are being sold to cover tax obligations related to vested equity awards.

Market Context: Transaction represents <0.001% of the company's $16.66B market cap.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Zai Lab Ltd

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Officer Rafael Amado is selling a small tranche of shares specifically to cover tax withholding obligations from a recent stock vest.
  • Market Impact: Neutral. The transaction volume is negligible relative to the company's market capitalization.

Company Information

FieldValue
CompanyZai Lab Ltd
CIK0001704292
IndustryPharmaceutical Preparations
Market Cap$16.66 Billion

Insider Information

FieldValue
NameAmado Rafael
CIK0001662119
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2026/03/13
Transaction CodeS (Sale)
Security TypeAmerican Depositary Shares
Shares Involved2,957
Price Per Share~$18.63 (Calculated)
Total Value$55,083.59
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$55,083.59
% of Market Cap0.00033%
Shares Transacted2,957
% of Shares Outstanding0.00026%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $16.66 billion, a $55k transaction is mathematically insignificant.
  • Transaction Significance: The transaction represents less than 0.001% of shares outstanding. The filing notes explicitly state this is a "sell-to-cover" transaction for taxes, which is a standard administrative action rather than a discretionary exit.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The volume is too low to impact the stock price, and the reason for the sale (tax obligations) removes any negative sentiment regarding insider confidence.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral. This is a mechanical transaction triggered by the vesting of restricted stock.

Additional Context

Transaction Notes

  • Tax Obligation: The remarks section confirms: "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."
  • Recent Activity: The insider also sold shares in December 2025 and earlier in March 2026, consistent with a vesting schedule.
Topics:#ZaiLab#Biotech#SECFiling#Form144#InsiderTrading#StockMarket#FinancialAnalysis#PharmaStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.